FDA Grants Approval for First Skin Cancer Drug
The U.S. Food and Drug Administration approved the first drug to treat basal cell carcinoma, the most common form of skin cancer, on Monday.
The U.S. Food and Drug Administration approved the first drug to treat basal cell carcinoma, the most common form of skin cancer, on Monday.